Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06348082 · ClinicalTrials.gov registry record · NA

Project Women's Insomnia Sleep Health Equity Study (WISHES)

A NA study of Insomnia and Cardiometabolic Health, sponsored by Yale University.

Recruiting
Registry status
NA
Development phase
340
Enrollment target
2
Study locations

NCT06348082 is a NA study of Insomnia and Cardiometabolic Health that is actively recruiting participants, run by Yale University. The registered enrollment target is 340 participants, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (102% higher). The trial reports 2 study locations across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06348082, a NA study of Insomnia and Cardiometabolic Health, is actively recruiting participants, sponsored by Yale University.

RECRUITING
Registry status
NA
Development phase
340 participants
Enrollment target
2
Study locations

Study Summary

The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.

Interventions

  • BEHAVIORAL Mindfulness-based therapy for insomnia (MBTI)

Study Locations (2)

Connecticut

  • Yale School of Nursing - New Haven
  • Yale School of Nursing Biobehavioral Lab - West Haven

Trial Details

FieldValue
Enrollment Target 340 participants
Start Date 2026-01-06
Est. Completion 2028-08-31
Phase NA

Sponsor

Yale University

1,492 total trials

What the Registry Record Tells You About NCT06348082

The ClinicalTrials.gov registry entry for NCT06348082 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 340 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 168-participant average among 151 other Insomnia trials with a reported enrollment target (102% higher). The listed sponsor is Yale University, which has 1,492 total studies on file at ClinicalTrials.gov.

The record links to 3 conditions, with Insomnia appearing as the primary indexed condition, and to 1 intervention - of which Mindfulness-based therapy for insomnia (MBTI) is the first listed.

NCT06348082 reports 2 study locations spanning 1 distinct geographic area - top geographies include Connecticut.

Frequently Asked Questions

What is clinical trial NCT06348082 about?

NCT06348082 is a clinical study titled "Project Women's Insomnia Sleep Health Equity Study (WISHES)". The purpose of this study is to achieve health and healthcare equity by implementing an equity-focused, mindfulness-based sleep intervention to reduce stress and sleep deficiency-related cardiometabolic disease burden in Black women.

What is the current status of trial NCT06348082?

This trial is currently recruiting. It is a NA study. The enrollment target is 340 participants. The study started on 2026-01-06. Estimated completion is 2028-08-31.

What conditions does trial NCT06348082 study?

This clinical trial studies the following conditions: Insomnia, Cardiometabolic Health, Sleep Health.

What interventions are being tested in trial NCT06348082?

The interventions under investigation include: Mindfulness-based therapy for insomnia (MBTI) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06348082?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06348082 being conducted?

This trial has 2 study locations across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Insomnia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.